2 unknown, 1 not yet recruiting, 1 recruiting. 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow JMKX001899: new trials by email Literature Review of JMKX001899 trials Research Report on JMKX001899
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC JMKX001899, Docetaxel - NSCLC (Non-small Cell Lung Cancer) | Phase 3 | Not yet recruiting | Jemincare | 472 | 2025-12-31 | 2025-11-21 |
| A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation JMKX001899, IN10018, Chemotherapy: Pemetrexed - NSCLC (Advanced Non-small Cell Lung Cancer) | Phase 1 | Recruiting | Jemincare | 72 | 2025-06-06 | 2025-07-01 |
| To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects JMKX001899, Placebo - Solid Tumor, Adult | Phase 1 | Unknown | Jemincare | 27 | 2024-07-10 | 2024-06-25 |
| Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects JMKX001899, Itraconazole, Midazolam - Solid Tumor, Adult | Phase 1 | Unknown | Jemincare | 72 | 2024-04-01 | 2024-04-04 |
Carcinoma, Non-Small-Cell Lung (2)
Jemincare (4)
China (2)
Jie Wang, Doctor (1) · Yilong Wu (1)